Every open market buy and sale of BridgeBio Pharma, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $90.8M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when BBIO insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an BBIO officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every BBIO insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 19, 2026 | Neil KumarCEO | Sale plan | 54,980 | $77.86 | $4.3M | 475,686 | Nov 20Form 4 |
| Oct 30, 2026 | Maricel ApuliChief Accounting Officer | Sale plan | 2,000 | $72.85 | $146K | 120,687 | Nov 3Form 4 |
| Sep 17, 2026 | Neil KumarCEO | Sale plan | 10,000 | $69.08 | $691K | 495,686 | Sep 21Form 4 |
| Aug 19, 2026 | Neil KumarCEO | Sale plan | 44,980 | $82.86 | $3.7M | 505,686 | Aug 20Form 4 |
| Jul 30, 2026 | Maricel ApuliChief Accounting Officer | Sale plan | 2,000 | $80.06 | $160K | 127,401 | Aug 3Form 4 |
| Jul 9, 2026 | Jennifer E. CookDirector | Sale plan | 148,589 | $88.54 | $13.2M | 8,383 | Jul 13Form 4 |
| Jul 9, 2026 | Andrea EllisDirector | Sale plan | 17,167 | $84.00 | $1.4M | 22,579 | Jul 13Form 4 |
| Jun 24, 2026 | Jennifer E. CookDirector | Sale plan | 39,363 | $69.92 | $2.8M | 8,383 | Jun 24Form 4 |
| Jun 23, 2026 | Hannah ValantineDirector | Sale plan | 5,004 | $68.25 | $342K | 9,259 | Jun 24Form 4 |
| Jun 15, 2026 | Jennifer E. CookDirector | Sale plan | 90,240 | $66.62 | $6M | 6,589 | Jun 17Form 4 |
| Jun 5, 2026 | Neil KumarCEO | Sale plan | 80,000 | $67.67 | $5.4M | 4,318,447 | Jun 8Form 4 |
| May 21, 2026 | Neil KumarCEO | Sale plan | 26,103 | $69.44 | $1.8M | 243,327 | May 26Form 4 |
| May 18, 2026 | Thomas TrimarchiPresident and CFO | Sale plan | 13,651 | $65.08 | $888K | 359,194 | May 19Form 4 |
| May 15, 2026 | Randal W. ScottDirector | Sale plan | 10,000 | $67.15 | $671K | 11,589 | May 19Form 4 |
| May 8, 2026 | Neil KumarCEO | Sale plan | 80,000 | $67.40 | $5.4M | 4,358,447 | May 11Form 4 |
BBIO insider trading FAQ
Are BBIO insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of BBIO on the open market in 0 trades, and 7 sold $90.8M in 32 trades, 100% of that under pre-arranged trading plans.
When did an BBIO insider last buy shares?
There has been no open market insider purchase of BBIO in the last two years.
When did an BBIO insider last sell shares?
Neil Kumar (CEO) sold 54,980 shares for $4.3M on Nov 19, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
